Dr. Yeckes-Rodin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1871 SE Tiffany Ave
Ste 100
Port St. Lucie, FL 34952Phone+1 772-355-5666Fax+1 772-335-3781
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2004 - 2007
Massachusetts General HospitalResidency, Internal Medicine, 2001 - 2004
University of Miami Leonard M. Miller School of MedicineClass of 2001
Certifications & Licensure
FL State Medical License 2007 - 2025
MA State Medical License 2003 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
Publications & Presentations
PubMed
- 16 citationsEganelisib, a First-in-Class PI3Kγ Inhibitor, in Patients with Advanced Solid Tumors: Results of the Phase 1/1b MARIO-1 Trial.David S Hong, Michael Postow, Bartosz Chmielowski, Ryan Sullivan, Amita Patnaik
Clinical Cancer Research. 2023-06-13 - 19 citationsBortezomib treatment causes remission in a Ph+ALL patient and reveals FoxO as a theranostic markerRajan Dewar, Sing Tsung Chen, Heather Yeckes-Rodin, Kenneth B. Miller, Roya Khosravi-Far
Cancer Biology & Therapy. 2011-03-15 - 4 citationsPhase 1/1b open-label, dose-escalation study of fruquintinib in patients with advanced solid tumors in the United States.Andrea Wang-Gillam, William Schelman, Stacey Ukrainskyj, Caly Chien, Martha Gonzalez
Investigational New Drugs. 2023-12-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
